{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T09:59:00Z","timestamp":1776247140682,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00520-023-07583-z","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T05:02:56Z","timestamp":1674622976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Management of genitourinary symptoms in patients with breast cancer: an updated systematic review of available evidence from randomized trials"],"prefix":"10.1007","volume":"31","author":[{"given":"Parvaneh","family":"Fallah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianna","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Clemons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Shorr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Vandermeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moira","family":"Rushton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"issue":"1","key":"7583_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.31083\/j.ejgo.2021.01.2130","volume":"42","author":"A Iop","year":"2021","unstructured":"Iop A et al (2021) Cytoplasmic pollen extract for treatment of menopausal symptoms in breast cancer patients: a case series report. Eur J Gynaecol Oncol 42(1):45\u201349","journal-title":"Eur J Gynaecol Oncol"},{"issue":"3","key":"7583_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/13697137.2012.756466","volume":"16","author":"A Sinha","year":"2013","unstructured":"Sinha A, Ewies AA (2013) Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview. Climacteric 16(3):305\u2013312. https:\/\/doi.org\/10.3109\/13697137.2012.756466","journal-title":"Climacteric"},{"key":"7583_CR3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/978-3-642-45769-2_38","volume":"152","author":"PA Ganz","year":"1998","unstructured":"Ganz PA, Rowland JH, Meyerowitz BE et al (1998) Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors. Recent Results Cancer Res 152:396\u2013411. https:\/\/doi.org\/10.1007\/978-3-642-45769-2_38","journal-title":"Recent Results Cancer Res"},{"issue":"1","key":"7583_CR4","doi-asserted-by":"publisher","first-page":"26e1","DOI":"10.1016\/j.ajog.2010.08.035","volume":"204","author":"J Baumgart","year":"2011","unstructured":"Baumgart J, Nilsson K, Stavreus-Evers A et al (2011) Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer. Am J Obstet Gynecol 204(1):26e1-26e7. https:\/\/doi.org\/10.1016\/j.ajog.2010.08.035","journal-title":"Am J Obstet Gynecol"},{"issue":"SUPPL 1","key":"7583_CR5","first-page":"S16","volume":"31","author":"AM Bianchi-Ferraro","year":"2020","unstructured":"Bianchi-Ferraro AM et al (2020) CO2 laser and microablative radiofrequency in the treatment of genitourinary syndrome of menopause and vulvovaginal atrophy in breast cancer survivors in use of antiestrogens: Impact in quality of life. Preliminary results of randomized controlled trial. Int Urogynecol J 31(SUPPL 1):S16\u2013S17","journal-title":"Int Urogynecol J"},{"issue":"3","key":"7583_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Rebecca L, Siegel MPH (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. ACS 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"ACS"},{"key":"7583_CR7","doi-asserted-by":"publisher","first-page":"CD001500","DOI":"10.1002\/14651858.CD001500","volume":"4","author":"J Suckling","year":"2006","unstructured":"Suckling J, Lethaby A, Kennedy R (2006) Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 4:CD001500. https:\/\/doi.org\/10.1002\/14651858.CD001500","journal-title":"Cochrane Database Syst Rev"},{"issue":"9407","key":"7583_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","volume":"363","author":"L Holmberg","year":"2004","unstructured":"Holmberg L, Anderson H (2004) HABITS (hormonal replacement therapy after breast cancer-is it safe?), a randomised comparison: trial stopped. Lancet 363(9407):453\u2013455. https:\/\/doi.org\/10.1016\/S0140-6736(04)15493-7","journal-title":"Lancet"},{"issue":"7","key":"7583_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/jnci\/dji071","volume":"97","author":"E von Schoultz","year":"2005","unstructured":"von Schoultz E, Rutgvist LE, Stockholm Breast Cancer Study Group (2005) Menopausal hormone therapy after breast cancer: the Stockholm randomized trial. J Natl Cancer Inst 97(7):533\u2013535. https:\/\/doi.org\/10.1093\/jnci\/dji071","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"7583_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejca.2012.07.003","volume":"49","author":"M Fahlen","year":"2013","unstructured":"Fahlen M, Fornander T, Johansson H et al (2013) Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial. Eur J Cancer 49(1):52\u201359. https:\/\/doi.org\/10.1016\/j.ejca.2012.07.003","journal-title":"Eur J Cancer"},{"key":"7583_CR11","doi-asserted-by":"crossref","unstructured":"Faubion SS, Kingsberg SA, Clark AL, Kaunitz AM, Spadt SK, Larkin LC, ... McClung MR (2020) The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause 27(9):976\u2013992","DOI":"10.1097\/GME.0000000000001609"},{"key":"7583_CR12","doi-asserted-by":"publisher","unstructured":"Melisko ME et al. (2020). Erratum: Vaginal testosterone cream vs estradiol vaginal ring for vaginal dryness or decreased libido in women receiving aromatase inhibitors for early-stage breast cancer: a randomized clinical trial (JAMA Oncology (2017) 3: 3 (313\u2013319) https:\/\/doi.org\/10.1001\/jamaoncol.2016.3904). JAMA Oncology 6(9): 1473","DOI":"10.1001\/jamaoncol.2016.3904"},{"issue":"1","key":"7583_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10549-019-05384-9","volume":"178","author":"A Booker","year":"2019","unstructured":"Booker A et al (2019) Vaginal CO2 laser for the treatment of vulvovaginal atrophy in women with breast cancer: LAAVA pilot study. Breast Cancer Res Treat 178(1):135\u2013140. https:\/\/doi.org\/10.1007\/s10549-019-05384-9","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"7583_CR14","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s00520-019-04684-6","volume":"27","author":"Z Keshavarzi","year":"2019","unstructured":"Keshavarzi Z et al (2019) The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer. Support Care Cancer 27(4):1325\u20131334. https:\/\/doi.org\/10.1007\/s00520-019-04684-6","journal-title":"Support Care Cancer"},{"issue":"3","key":"7583_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1634\/theoncologist","volume":"13","author":"M Trinkaus","year":"2008","unstructured":"Trinkaus M, Chin S, Wolfman W et al (2008) Should urogenital atrophy in breast cancer survivors be treated with topical estro- gens? Oncologist 13(3):222\u2013231. https:\/\/doi.org\/10.1634\/theoncologist","journal-title":"Oncologist"},{"issue":"2","key":"7583_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3816\/CBC.2009.n.020","volume":"9","author":"SN Chin","year":"2009","unstructured":"Chin SN, Trinkaus M, Simmons C et al (2009) Prevalence and severity of urogenital symptoms in postmenopausal women re- ceiving endocrine therapy for breast cancer. Clin Breast Cancer 9(2):108\u2013117. https:\/\/doi.org\/10.3816\/CBC.2009.n.020","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"7583_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-015-3434-z","volume":"152","author":"S Mazzarello","year":"2015","unstructured":"Mazzarello S, Hutton B, Ibrahim MFK, Jacobs C, Shorr R, Smith S, Ng T, Clemons M (2015) Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials. Breast Cancer Res Treat 152(1):1\u20138. https:\/\/doi.org\/10.1007\/s10549-015-3434-z","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"7583_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13643-018-0699-4","volume":"7","author":"MJ Page","year":"2018","unstructured":"Page MJ, Shamseer L, Tricco AC (2018) Registration of systematic reviews in PROSPERO: 30,000 records and counting. Syst Rev 7(1):32. https:\/\/doi.org\/10.1186\/s13643-018-0699-4","journal-title":"Syst Rev"},{"key":"7583_CR19","doi-asserted-by":"publisher","first-page":"5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:5928. https:\/\/doi.org\/10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"7583_CR20","doi-asserted-by":"publisher","unstructured":"Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, McKenzie JE. (2021) PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 372(160). https:\/\/doi.org\/10.1136\/bmj.n160","DOI":"10.1136\/bmj.n160"},{"issue":"4","key":"7583_CR21","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/AOG.0b013e3182118790","volume":"117","author":"YK Lee","year":"2011","unstructured":"Lee YK, Chung HH, Kim JW et al (2011) Vaginal pH-balanced gel for the control of atrophic vaginitis among breast cancer survivors: a randomized controlled trial. Obstet Gynecol 117(4):922\u2013927. https:\/\/doi.org\/10.1097\/AOG.0b013e3182118790","journal-title":"Obstet Gynecol"},{"issue":"3","key":"7583_CR22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1200\/JCO.1997.15.3.969","volume":"15","author":"CL Loprinzi","year":"1997","unstructured":"Loprinzi CL, Abu-Ghazaleh S, Sloan JA et al (1997) Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer. J Clin Oncol 15(3):969\u2013973. https:\/\/doi.org\/10.1200\/JCO.1997.15.3.969","journal-title":"J Clin Oncol"},{"issue":"8","key":"7583_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.clon.2012.06.009","volume":"24","author":"CE Simmons","year":"2012","unstructured":"Simmons CE, Kuchuk I, Freedman OC et al (2012) Are Estring(R) and Vagifem(R) equally effective and safe for the treatment of urogenital atrophy in breast cancer patients on aro- matase inhibitor therapy? Clin Oncol (R Coll Radiol) 24(8):128\u2013129. https:\/\/doi.org\/10.1016\/j.clon.2012.06.009","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"30","key":"7583_CR24","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1200\/JCO.2014.60.7366","volume":"33","author":"MF Goetsch","year":"2015","unstructured":"Goetsch MF et al (2015) A practical solution for dyspareunia in breast cancer survivors: a randomized controlled trial. J Clin Oncol 33(30):3394\u20133400. https:\/\/doi.org\/10.1200\/JCO.2014.60.7366","journal-title":"J Clin Oncol"},{"issue":"4","key":"7583_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11764-017-0606-3","volume":"11","author":"P Advani","year":"2017","unstructured":"Advani P et al (2017) A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy. J Cancer Surviv 11(4):477\u2013485. https:\/\/doi.org\/10.1007\/s11764-017-0606-3","journal-title":"J Cancer Surviv"},{"issue":"1","key":"7583_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/13697137.2016.1258396","volume":"20","author":"PT Juliato","year":"2017","unstructured":"Juliato PT et al (2017) Can polyacrylic acid treat sexual dysfunction in women with breast cancer receiving tamoxifen? Climacteric 20(1):62\u201366. https:\/\/doi.org\/10.1080\/13697137.2016.1258396","journal-title":"Climacteric"},{"issue":"11","key":"7583_CR27","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.1210\/jc.2018-01345","volume":"103","author":"SR Davis","year":"2018","unstructured":"Davis SR et al (2018) Intravaginal testosterone improves sexual satisfaction and vaginal symptoms associated with aromatase inhibitors. J Clin Endocrinol Metab 103(11):4146\u20134154. https:\/\/doi.org\/10.1210\/jc.2018-01345","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"7583_CR28","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1097\/AOG.0000000000001988","volume":"129","author":"YH Kim","year":"2017","unstructured":"Kim YH et al (2017) Effect of a pH-balanced vaginal gel on dyspareunia and sexual function in breast cancer survivors who were premenopausal at diagnosis: a randomized controlled trial. Obstet Gynecol 129(5):870\u2013876. https:\/\/doi.org\/10.1097\/AOG.0000000000001988","journal-title":"Obstet Gynecol"},{"issue":"5","key":"7583_CR29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/GME.0000000000001497","volume":"27","author":"AL Hirschberg","year":"2020","unstructured":"Hirschberg AL et al (2020) Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial. Menopause (New York, N.Y.) 27(5):526\u2013534. https:\/\/doi.org\/10.1097\/GME.0000000000001497","journal-title":"Menopause (New York, N.Y.)"},{"key":"7583_CR30","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) (2003) Estrogen and estrogen\/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms \u2014 recommendations for clinical evaluation"},{"issue":"21","key":"7583_CR31","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1200\/JCO.2004.08.029","volume":"22","author":"L Fallowfield","year":"2004","unstructured":"Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A (2004) Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial. J Clin Oncol 22(21):4261\u20134271. https:\/\/doi.org\/10.1200\/JCO.2004.08.029","journal-title":"J Clin Oncol"},{"key":"7583_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40695-015-0009-4","volume":"1","author":"SM Seav","year":"2015","unstructured":"Seav SM et al (2015) Management of sexual dysfunction in breast cancer survivors: a systematic review. Women\u2019s Midlife Health 1:9. https:\/\/doi.org\/10.1186\/s40695-015-0009-4","journal-title":"Women's Midlife Health"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07583-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-07583-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07583-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T23:31:28Z","timestamp":1676331088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-07583-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["7583"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-07583-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"assertion":[{"value":"5 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable as this was a systematic review of previously published studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics committee approval"}},{"value":"Not applicable as this was a systematic review of previously published studies.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable as this was a systematic review of previously published studies.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"131"}}